International Symposium on Viral Infections in CFS
Do viruses and other pathogens play a role in CFS? Roughly 10%
of patients who get acute EBV mononucleosis or Ross River fever
end up with CFS. Do these infections trigger other processes
or is there an ongoing infection that cannot be detected in the
peripheral blood? Do CFS investigators need to look in the stomach
antrum, cardiac tissue or or brain tissue of CFS patients instead
of the peripheral blood? What role do pathogens such as parvovirus
B-19, HHV-6, enterovirus, Borna virus or EBV play in CFS? These
questions will be discussed at our special symposium immediately
after the end of the main conference on June 22nd through Monday,
June 23rd. One special highlight: Jose Montoya hopes to disclose
his findings for the trial of Valcyte in CFS patients with elevated
antibodies to HHV-6 and EBV.
Speakers to include (list incomplete):
- Liv Bode,
PhD, Robert Koch Institute, Germany (Borna virus in CFS)
- Nora Chapman, PhD, University of Nebraska Medical Center
(Enterovirus overview)
- John Chia, MD, UCLA & EV Med Research,
California, USA (enterovirus in CFS )
- Kenny De Meirleir, MD,
PhD, Himmunitas Foundation, Belgium (RNaseL activity
and virus)
- Birgitta Evengard, MD, PhD, Umeå University, Umeå,
Sweden (viral markers in CFS)
- Brigitte Huber, PhD, Tufts University,
Boston, MA, USA (EBV and interferon activation
of retrovirus K-18 in CFS)
- Jonthan Kerr, MD, PhD, St. George’s,
University of London, UK (Gene expression subtypes
in patients with CFS and ME)
- Nancy Klimas, MD, University of Miami, Florida, USA (Immune
function, CFS and viral illness )
- Anthony Komaroff, MD, Harvard
Medical School, Boston, USA (HHV-6 in CFS)
- Kazuhiro Kondo, MD, PhD, Jikei University
School of Medicine, Tokyo, Japan (HHV-6 & 7 infections in fatigue & mood
disorders)
- Andrew Lloyd, MD, UNSW School of Medical Sciences,
Australia (post-viral fatigue)
- Jose Montoya, MD, Stanford University,
USA (Antiviral treatment of CFS patients )
- Dan Peterson, MD, Sierra Internal Medicine,
Incline Village, USA (novel viruses in CFS)
- Barbara Savoldo, MD, Baylor College
of Medicine, (chronic active EBV and cytotoxic T-cell
immunotherapy)
- Mariko Seishima,
MD, Ogaki Municipal Hospital, Japan (Parvovirus infections
in CFS)
- Keizo Tomonga, PhD, DVM, Osaka University,
Japan (Borna virus in CFS)
- Suzanne Vernon, PhD, CFIDS Association of America,
USA (Host genetics and viral infection)
- Peter White, MD, St Barts Hospital,
Queen Mary School of Medicine, London UK, (Overview
on Post-Viral Fatigue)
- Ute Vollmer-Conna,
PhD, University of South New Wales (cytokines in post
viral fatigue)
- Marshall Williams, PhD, Ohio State University,
USA (EBV DUTPase in fatigue)
|
|
Symposium Topics
- HHV-6 & 7 in CFS
- Microarray studies
- Borna virus in CFS
- Chronic EBV in CFS
- Post infective CFS / Prospective
studies
- Parovirus B-19 in CFS
- Retrovirus K-18 activation
by EBV and interferon
- Enterovirus in CFS
Symposium Co-Chairs:
Anthony Komaroff, MD
Andrew Lloyd, MD
Sponsored by
HHV-6 Foundation & IACFS/ME
Co-Sponsored by
National CFIDS Association, Epiphany
Biosciences, Whittemore-Peterson Institute and Angel Donors
Committee List
Program, Advisory and Organizing
committees
Interested only in the Symposium on Viruses in CFS but not the
main conference?
Many of the participants of the Symposium will
attend the International Conference on HHV-6 & 7 which will
be held June 20-22nd. Satellite Symposium registrants are invited
to arrive early on Sunday for the morning sessions on HHV-6 in
CNS disease. This will include sessions on HHV-6 encephalitis,
HHV-6B in mesial temporal lobe epilepsy and HHV-6A in multiple
sclerosis.
Register here if you would like
to attend only the International Symposium on Viruses in CFS (with
the option to attend the last three main conference sessions
on HHV-6 in CNS Disease)
Click here to get more information
on the 6th International Conference on HHV-6 & 7
For more information, contact: Courtney_Hischier@HHV-6Foundation.org
|
